Penicillamine in Metal Poisoning

Overview

Journal J Rheumatol Suppl

Specialty Rheumatology

Date 1981 Jan 1

PMID 6939892

Citations 4

Authors

W H Lyle

Affiliations

Soon will be listed here.

Abstract

Penicillamine is used to treat heavy metal poisonings because it forms complexes in vitro with several toxic metals, including lead, cadmium, mercury, and gold. Urinary excretion of lead is immediately, markedly increased by penicillamine, but this is not true for the urinary excretion of cadmium, mercury, and gold. There is evidence that cadmium is shifted from 1 binding site to another in vivo; this may also be true of mercury and gold. Whether the effects of such possible shifts are beneficial or adverse is unknown.

Citing Articles

D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective.

Pugliese M, Biondi V, Gugliandolo E, Licata P, Peritore A, Crupi R Antibiotics (Basel). 2021; 10(6).

PMID: 34071639 PMC: 8229433. DOI: 10.3390/antibiotics10060648.

DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease.

Krishnan N, Felice C, Rivera K, Pappin D, Tonks N Genes Dev. 2018; 32(13-14):944-952.

PMID: 29945887 PMC: 6075031. DOI: 10.1101/gad.314658.118.

Study of Crystal Formation and Nitric Oxide (NO) Release Mechanism from -Nitroso--acetylpenicillamine (SNAP)-Doped CarboSil Polymer Composites for Potential Antimicrobial Applications.

Wo Y, Li Z, Colletta A, Wu J, Xi C, Matzger A Compos B Eng. 2017; 121:23-33.

PMID: 28989300 PMC: 5625630. DOI: 10.1016/j.compositesb.2017.03.027.

Clinical pharmacokinetics of D-penicillamine.

Netter P, Bannwarth B, Pere P, Nicolas A Clin Pharmacokinet. 1987; 13(5):317-33.

PMID: 3319347 DOI: 10.2165/00003088-198713050-00003.